ConcertAI
ConcertAI is a healthcare AI and real-world data company serving oncology and other complex disease areas. Founded in 2018 and headquartered in Boston and Plymouth Meeting, Pennsylvania, it combines curated real-world clinical, genomic and imaging data with applied AI for life sciences, biopharma and provider organizations. Its portfolio includes the CARA AI engine, the Precision Suite (Precision360, Precision Explorer, Translational360, Patient360), the CancerLinQ Suite acquired from ASCO, clinical trial products (ACT, TriaLinQ, Precision Trials), commercial products (Cadence Suite, Data Foundry, Precision GTM), and the TeraRecon enterprise imaging and Eureka Clinical AI platform. ConcertAI publishes no public developer portal, API reference or machine-readable specification; platform access is through the authenticated Precision application and integration is arranged through a partner/sales motion.
ConcertAI is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Oncology, Artificial Intelligence, and Real-World Data.
ConcertAI’s developer surface includes engineering blog, support, product news, authentication, and 13 more developer resources.
Kin Score
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Scopes 1
OAuth scopes governing access to this provider's APIs.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Access & Security 3
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
Other 2
Properties that don't map to a standard resource type